Skip to main content
Equibles

Daniel J. Brennan

Board Member

Madrigal Pharmaceuticals, Inc. (MDGL)

Equibles does not estimate personal net worth.

Get an email with a short summary when Madrigal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get MDGL alerts

About Daniel J. Brennan

Daniel J. Brennan is recorded as Board Member at Madrigal Pharmaceuticals, Inc. (MDGL) since April 22, 2026. The newest filing on record that lists Daniel J. Brennan as Board Member at Madrigal Pharmaceuticals, Inc. (MDGL) is dated April 28, 2026. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed April 28, 2026 that Daniel J. Brennan was appointed Class I director, effective April 22, 2026. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed April 28, 2026 that Daniel J. Brennan resigned as Class II director, effective April 22, 2026. Madrigal Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Madrigal Pharmaceuticals, Inc. includes Bill Sibold (CEO and Board Member), Julian C. Baker (Chairman and Board Member), Mardi Dier (CFO) and 7 others.

“The Board accepted each resignation and simultaneously reappointed each of Mr. Baker and Mr. Brennan as a Class I director.”
Madrigal Pharmaceuticals, Inc. Form 8-K, filed April 28, 2026 · Read the filing
“Each of Mr. Baker and Mr. Brennan resigned from his position as a Class III and Class II director, respectively, subject to and conditioned upon his simultaneous reappointment as a Class I director.”
Madrigal Pharmaceuticals, Inc. Form 8-K, filed April 28, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Madrigal Pharmaceuticals, Inc.

Recent activity